249eP Efficacy and safety of interventional therapy combined with sintilimab plus bevacizumab for hepatocellular carcinoma patients with the macrovascular invasion (MVI): A real-world study

作者：H. Gong, X. Wang, P. Li, Min Li, Jianmin Wu, M. Ye · 发表于：Annals of Oncology · 年份：2026 · DOI：10.1016/j.annonc.2026.05.291 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Liver physiology and pathology